Literature DB >> 29802621

Emerging concepts of ganglioside metabolism.

Roger Sandhoff1, Konrad Sandhoff2.   

Abstract

Gangliosides (GGs) are sialic acid-containing glycosphingolipids (GSLs) and major membrane components enriched on cellular surfaces. Biosynthesis of mammalian GGs starts at the cytosolic leaflet of endoplasmic reticulum (ER) membranes with the formation of their hydrophobic ceramide anchors. After intracellular ceramide transfer to Golgi and trans-Golgi network (TGN) membranes, anabolism of GGs, as well as of other GSLs, is catalyzed by membrane-spanning glycosyltransferases (GTs) along the secretory pathway. Combined activity of only a few promiscuous GTs allows for the formation of cell-type-specific glycolipid patterns. Following an exocytotic vesicle flow to the cellular plasma membranes, GGs can be modified by metabolic reactions at or near the cellular surface. For degradation, GGs are endocytosed to reach late endosomes and lysosomes. Whereas membrane-spanning enzymes of the secretory pathway catalyze GSL and GG formation, a cooperation of soluble glycosidases, lipases and lipid-binding cofactors, namely the sphingolipid activator proteins (SAPs), act as the main players of GG and GSL catabolism at intralysosomal luminal vesicles (ILVs).
© 2018 Federation of European Biochemical Societies.

Entities:  

Keywords:  catabolism; endocytosis; enzyme catalysis; gangliosides; lipid-binding proteins; membrane lipids; metabolic diseases; organellar membranes; sphingolipids; topology

Mesh:

Substances:

Year:  2018        PMID: 29802621     DOI: 10.1002/1873-3468.13114

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  25 in total

1.  Molecular Mechanism of the Flexible Glycan Receptor Recognition by Mumps Virus.

Authors:  Marie Kubota; Rei Matsuoka; Tateki Suzuki; Koji Yonekura; Yusuke Yanagi; Takao Hashiguchi
Journal:  J Virol       Date:  2019-07-17       Impact factor: 5.103

2.  Bacterial immunogenic α-galactosylceramide identified in the murine large intestine: dependency on diet and inflammation.

Authors:  Johanna von Gerichten; Dominic Lamprecht; Lukáš Opálka; Daphnée Soulard; Christian Marsching; Robert Pilz; Valentin Sencio; Silke Herzer; Bruno Galy; Viola Nordström; Carsten Hopf; Hermann-Josef Gröne; François Trottein; Roger Sandhoff
Journal:  J Lipid Res       Date:  2019-09-04       Impact factor: 5.922

3.  Membrane lipids and their degradation compounds control GM2 catabolism at intralysosomal luminal vesicles.

Authors:  Susi Anheuser; Bernadette Breiden; Konrad Sandhoff
Journal:  J Lipid Res       Date:  2019-04-15       Impact factor: 5.922

4.  Gangliosides in Neurodegenerative Diseases.

Authors:  Robert Ledeen; Suman Chowdhury
Journal:  Adv Neurobiol       Date:  2023

5.  Neuronal Ganglioside and Glycosphingolipid (GSL) Metabolism and Disease : Cascades of Secondary Metabolic Errors Can Generate Complex Pathologies (in LSDs).

Authors:  Roger Sandhoff; Konrad Sandhoff
Journal:  Adv Neurobiol       Date:  2023

6.  Crystal structures of human lysosomal EPDR1 reveal homology with the superfamily of bacterial lipoprotein transporters.

Authors:  Yong Wei; Zi Jian Xiong; Jun Li; Chunxia Zou; Christopher W Cairo; John S Klassen; Gilbert G Privé
Journal:  Commun Biol       Date:  2019-02-05

Review 7.  Mechanism of Secondary Ganglioside and Lipid Accumulation in Lysosomal Disease.

Authors:  Bernadette Breiden; Konrad Sandhoff
Journal:  Int J Mol Sci       Date:  2020-04-07       Impact factor: 5.923

8.  Impaired β-glucocerebrosidase activity and processing in frontotemporal dementia due to progranulin mutations.

Authors:  Andrew E Arrant; Jonathan R Roth; Nicholas R Boyle; Shreya N Kashyap; Madelyn Q Hoffmann; Charles F Murchison; Eliana Marisa Ramos; Alissa L Nana; Salvatore Spina; Lea T Grinberg; Bruce L Miller; William W Seeley; Erik D Roberson
Journal:  Acta Neuropathol Commun       Date:  2019-12-23       Impact factor: 7.801

Review 9.  Glucocerebrosidase: Functions in and Beyond the Lysosome.

Authors:  Daphne E C Boer; Jeroen van Smeden; Joke A Bouwstra; Johannes M F G Aerts
Journal:  J Clin Med       Date:  2020-03-09       Impact factor: 4.241

Review 10.  Glycosphingolipids and Infection. Potential New Therapeutic Avenues.

Authors:  Johannes M F G Aerts; M Artola; M van Eijk; M J Ferraz; R G Boot
Journal:  Front Cell Dev Biol       Date:  2019-12-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.